Fully Automated Atlas-Based MR Imaging Volumetry in Huntington Disease, Compared with Manual Volumetry

References

1. 1.↵
   1. Bohanna I,
   2. Georgiou-Karistianis N,
   3. Hannan AJ,
   4. et al

   . Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res Rev 2008;58:209–25

   CrossRefPubMed
2. 2.↵
   1. Kloppel S,
   2. Henley SM,
   3. Hobbs NZ,
   4. et al

   . Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience 2009;164:205–19. Epub 2009 Jan 29

   CrossRefPubMed
3. 3.↵
   1. Kassubek J,
   2. Juengling FD,
   3. Kioschies T,
   4. et al

   . Topography of cerebral atrophy in early Huntington's disease: a voxel-based morphometric MRI study. J Neurol Neurosurg Psychiatry 2004;75:213–20

   Abstract/FREE Full Text
4. 4.↵
   1. Henley SM,
   2. Ridgway GR,
   3. Scahill RI,
   4. et al

   . Pitfalls in the use of voxel-based morphometry as a biomarker: examples from Huntington disease. AJNR Am J Neuroradiol 2010;31:711–19

   Abstract/FREE Full Text
5. 5.↵
   1. Huppertz HJ,
   2. Kroll-Seger J,
   3. Danek A,
   4. et al

   . Automatic striatal volumetry allows for identification of patients with chorea-acanthocytosis at single subject level. J Neural Transm 2008;115:1393–400. Epub 2008 Jul 22

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Huppertz HJ,
   2. Kroll-Seger J,
   3. Kloppel S,
   4. et al

   . Intra- and interscanner variability of automated voxel-based volumetry based on a 3D probabilistic atlas of human cerebral structures. Neuroimage 2010;49:2216–24

   CrossRefPubMed
7. 7.↵
   1. Shattuck DW,
   2. Mirza M,
   3. Adisetiyo V,
   4. et al

   . Construction of a 3D probabilistic atlas of human cortical structures. Neuroimage 2008;39:1064–80

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Ashburner J,
   2. Friston KJ

   . Voxel-based morphometry: the methods. Neuroimage 2000;11(6 pt 1):805–21

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Lemieux L,
   2. Wieshmann UC,
   3. Moran NF,
   4. et al

   . The detection and significance of subtle changes in mixed-signal brain lesions by serial MRI scan matching and spatial normalization. Med Image Anal 1998;2:227–42

   CrossRefPubMed
10. 10.↵
    1. Looi JC,
    2. Svensson L,
    3. Lindberg O,
    4. et al

    . Putaminal volume in frontotemporal lobar degeneration and Alzheimer disease: differential volumes in dementia subtypes and controls. AJNR Am J Neuroradiol 2009;30:1552–60

    Abstract/FREE Full Text
11. 11.↵
    1. Looi JC,
    2. Tatham V,
    3. Kumar R,
    4. et al

    . Caudate nucleus volumes in stroke and vascular dementia. Psychiatry Res 2009;174:67–75

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Bland JM,
    2. Altman DG

    . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–10

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Lin LI

    . A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255–68

    CrossRefPubMedWeb of Science
14. 14.↵
    1. van Elst LT,
    2. Woermann FG,
    3. Lemieux L,
    4. et al

    . Affective aggression in patients with temporal lobe epilepsy: a quantitative MRI study of the amygdala. Brain 2000;123(pt 2):234–43

    Abstract/FREE Full Text
15. 15.↵
    1. Rosas HD,
    2. Feigin AS,
    3. Hersch SM

    . Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease. NeuroRx 2004;1:263–72

    Abstract/FREE Full Text
16. 16.↵
    1. Wild EJ,
    2. Henley SM,
    3. Hobbs NZ,
    4. et al

    . Rate and acceleration of whole-brain atrophy in premanifest and early Huntington's disease. Mov Disord 2010;25:888–95

    CrossRefPubMed
17. 17.↵
    1. Aylward EH,
    2. Rosenblatt A,
    3. Field K,
    4. et al

    . Caudate volume as an outcome measure in clinical trials for Huntington's disease: a pilot study. Brain Res Bull 2003;62:137–41

    CrossRefPubMed
18. 18.↵
    1. Paulsen JS,
    2. Nopoulos PC,
    3. Aylward E,
    4. et al

    . Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 2010;82:201–07

    CrossRefPubMedWeb of Science